참고문헌
- Basu B, Correa de Sampaio P, Mohammed H, et al (2012). Inhibition of MT1-MMP activity using functional antibody fragments selected against its hemopexin domain. Int J Biochem Cell Biol, 44, 393-403. https://doi.org/10.1016/j.biocel.2011.11.015
- Blackwell GJ, Carnuccio R, Di Rosa M, et al (1980). Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature, 287, 147-9. https://doi.org/10.1038/287147a0
- Cao Y, Li Y, Edelweiss M, et al (2008). Loss of annexin A1 expression in breast cancer progression. Appl Immunohistochem Mol Morphol, 16, 530-4. https://doi.org/10.1097/PAI.0b013e31817432c3
- Chakraborty A, Dutta J, Das S, et al (2013). Comparison of ex vivo cultivated human limbal epithelial stem cell viability and proliferation on different substrates. Int Ophthalmol, 33, 665-70. https://doi.org/10.1007/s10792-013-9765-z
- Chao YL, Shepard CR, Wells A (2010). Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer, 9, 179. https://doi.org/10.1186/1476-4598-9-179
- Chen CY, Shen JQ, Wang F, Wan R, Wang XP (2012). Prognostic significance of annexin A1 expression in pancreatic ductal adenocarcinoma. Asian Pac J Cancer Prev, 13, 4707-12. https://doi.org/10.7314/APJCP.2012.13.9.4707
- Flower RJ, Blackwell GJ (1979). Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature, 278, 456-9. https://doi.org/10.1038/278456a0
- Hongsrichan N, Rucksaken R, Chamgramol Y, et al (2013). Annexin A1: A new immunohistological marker of cholangiocarcinoma. World J Gastroenterol, 19, 2456-65. https://doi.org/10.3748/wjg.v19.i16.2456
- Hynes RO (2003). Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both? Cell, 113, 821-3. https://doi.org/10.1016/S0092-8674(03)00468-9
- Inokuchi J, Lau A, Tyson DR, et al (2009). Loss of annexin A1 disrupts normal prostate glandular structure by inducing autocrine IL-6 signaling. Carcinogenesis, 30, 1082-8. https://doi.org/10.1093/carcin/bgp078
- Kang JS, Calvo BF, Maygarden SJ, et al (2002). Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res, 8, 117-23.
- Keleg S, Buchler P, Ludwig R, et al (2003). Invasion and metastasis in pancreatic cancer. Mol Cancer, 2, 14. https://doi.org/10.1186/1476-4598-2-14
- Li Y, Wen T, Zhu M, et al (2013). Glycoproteomic analysis of tissues from patients with colon cancer using lectin microarrays and nanoLC-MS/MS. Mol Biosyst, 9, 1877-87. https://doi.org/10.1039/c3mb00013c
- Lim LH, Pervaiz S (2007). Annexin 1: the new face of an old molecule. FASEB J, 21, 968-75. https://doi.org/10.1096/fj.06-7464rev
- Nan Y, Yang S, Tian Y, et al (2009). Analysis of the expression protein profiles of lung squamous carcinoma cell using shot-gun proteomics strategy. Med Oncol, 26, 215-21. https://doi.org/10.1007/s12032-008-9109-4
- Schittenhelm J, Trautmann K, Tabatabai G, et al (2009). Comparative analysis of annexin-1 in neuroepithelial tumors shows altered expression with the grade of malignancy but is not associated with survival. Mod Pathol, 22, 1600-11. https://doi.org/10.1038/modpathol.2009.132
- Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
- Swa HL, Shaik AA, Lim LH, et al (2014). Mass spectrometry-based quantitative proteomics and integrative network analysis accentuates modulating roles of Annexin-1 in mammary tumorigenesis. Proteomics.
- Wells A, Griffith L, Wells JZ, et al (2013). The dormancy dilemma: quiescence versus balanced proliferation. Cancer Res, 73, 3811-6. https://doi.org/10.1158/0008-5472.CAN-13-0356
- Yates C, Shepard CR, Papworth G, et al (2007). Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression. Adv Cancer Res, 97, 225-46. https://doi.org/10.1016/S0065-230X(06)97010-9
- Yu G, Wang J, Chen Y, et al (2008). Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer. Clin Exp Metastasis, 25, 695-702. https://doi.org/10.1007/s10585-008-9178-y
- Zeng GQ, Cheng AL, Tang J, et al (2013). Annexin A1: A new biomarker for predicting nasopharyngeal carcinoma response to radiotherapy. Med Hypotheses, 81, 68-70. https://doi.org/10.1016/j.mehy.2013.04.019
피인용 문헌
- The restorative role of annexin A1 at the blood–brain barrier vol.13, pp.1, 2016, https://doi.org/10.1186/s12987-016-0043-0
- Evaluation of miRNA-196a2 and apoptosis-related target genes: ANXA1, DFFA and PDCD4 expression in gastrointestinal cancer patients: A pilot study vol.12, pp.11, 2017, https://doi.org/10.1371/journal.pone.0187310
- iTRAQ-based quantitative proteomic analysis of differentially expressed proteins in chemoresistant nasopharyngeal carcinoma vol.19, pp.9, 2018, https://doi.org/10.1080/15384047.2018.1472192